Utilization of Bone-Anchored Annular Defect Closure to Prevent Reherniation Following Lumbar Discectomy: Overcoming Barriers to Clinical Adoption and Market …

MP Lorio, WC Watters, BH Grunch… - International Journal of …, 2024 - ijssurgery.com
While achieving premarket approval from the US Food and Drug Administration represents a
significant milestone in the development and commercialization of a Class III medical …

[HTML][HTML] Multicenter study of lumbar discectomy with Barricaid annular closure device for prevention of lumbar disc reherniation in US patients: a historically controlled …

KB Strenge, CP DiPaola, LE Miller, CP Hill… - Medicine, 2019 - journals.lww.com
Background: Patients with large defects in the annulus fibrosus following lumbar discectomy
have high rates of symptomatic reherniation. The Barricaid annular closure device provides …

[HTML][HTML] Lumbar disc reherniation prevention with a bone-anchored annular closure device: 1-year results of a randomized trial

W van den Brink, C Flüh, LE Miller, PD Klassen… - Medicine, 2019 - journals.lww.com
Background: The risk of recurrent herniation after lumbar discectomy is highest during the
first postoperative year. The purpose of this study was to determine whether implantation of …

Expert review with meta-analysis of randomized and nonrandomized controlled studies of Barricaid annular closure in patients at high risk for lumbar disc reherniation

LE Miller, RT Allen, B Duhon… - Expert review of medical …, 2020 - Taylor & Francis
Introduction: Patients with lumbar disc herniation and associated sciatica are often referred
for lumbar discectomy. The surgical defect in the annulus fibrosus is typically left unrepaired …

[HTML][HTML] Cost-effectiveness of a bone-anchored annular closure device versus conventional lumbar discectomy in treating lumbar disc herniations

J Ament, B Thaci, Z Yang, E Kulubya, W Hsu, G Bouma… - 2019 - journals.lww.com
Study Design. Cost-utility analysis of an annular closure device (ACD) based on data from a
prospective, multicenter randomized controlled trial (RCT) Objective. The aim of this study …

Postoperative direct health care costs of lumbar discectomy are reduced with the use of a novel annular closure device in high-risk patients

JD Ament, B Thaci, Z Yang, A Kursumovic… - The Spine Journal, 2019 - Elsevier
ABSTRACT BACKGROUND CONTEXT Lumbar discectomy is largely successful surgical
procedure; however, reherniation rates in patients with large annular defects are as high as …

International Society for the Advancement of Spine Surgery Policy 2019—surgical treatment of lumbar disc herniation with radiculopathy

M Lorio, C Kim, A Araghi, J Inzana… - International Journal of …, 2020 - ijssurgery.com
Lumbar disc herniation (LDH) is a frequent cause of low back pain and radiculopathy,
disability, and diminution in quality of life. While nonsurgical care remains the mainstay of …

Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure …

PD Klassen, WK Hsu, F Martens, JA Inzana… - ClinicoEconomics …, 2018 - Taylor & Francis
Introduction Lumbar discectomy patients with large annular defects are at a high risk for
reherniation and reoperation, which could be mitigated through the use of an annular …

Cost savings associated with prevention of recurrent lumbar disc herniation with a novel annular closure device: a multicenter prospective cohort study

SL Parker, G Grahovac, D Vukas… - … Surgery Part A …, 2013 - thieme-connect.com
Objective Same-level recurrent disc herniation is a well-defined complication following
lumbar discectomy. Reherniation results in increased morbidity and health care costs …

[HTML][HTML] Lumbar discectomy with Barricaid device implantation in patients at high risk of reherniation: initial results from a postmarket study

P Nunley, KB Strenge, K Huntsman, H Bae, C DiPaola… - Cureus, 2021 - ncbi.nlm.nih.gov
Background Patients with large defects in the annulus fibrosus following lumbar discectomy
have high rates of symptomatic reherniation and reoperation. An FDA randomized controlled …